RELATED PRODUCTS NOT AVAILABLE
true
Support
Becton Dickinson Australia & New Zealand
AU: 1800 656 100
NZ: 0800 572 468
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
For more information, please visit our Contact Us page
- Overview
- Products & Accessories
- EIFU & Resources
- Unique helical design engineered for bending, compression, torsion
- The LifeStent™ 5F Vascular Stent System is indicated for the treatment of atherosclerotic lesions in the superficial femoral artery (SFA) and popliteal artery.
- Low profile, 5F delivery system
- Dual-speed thumbwheel deployment designed for ease of use and placement accuracy2
- GeoAlign™ Marking System designed to increase procedural efficiency and reduce radiation exposure3
Clinically Proven Stent Design:
For the superficial femoral and full popliteal artery, the LifeStent™ Vascular Stent has a history of proven performance
- In a Level 1 RESILIENT study, the LifeStent™ Vascular Stent demonstrated treatment superiority over balloon angioplasty with sustained effectiveness out to 3 years4
- In the investigator initiated, Level 1 ETAP study of the popliteal artery the LifeStent™ Vascular Stent demonstrated double the primary patency rate of PTA out to two years5
- In a clinical assessment of the treatment of long lesions, the LifeStent™ Vascular Stent demonstrated high primary patency at 12 months in lesions up to 240mm6
Low Profile, 5F Delivery System:
The LifeStent™ 5F Vascular Stent System offers the same clinically-proven advanced helical stent design as the LifeStent™ Vascular Stent on a low profile, 5F delivery system. The LifeStent™ 5F delivery system offers dual speed thumbwheel deployment with a tri-axial catheter that is designed for ease of use, deployment control, and precise placement accuracy.2
The LifeStent™ 5F Vascular Stent System is part of the Bard 5F ProSeries™ suite of low profile products designed to minimize arteriotomy size and enable physicians to complete a 5F procedure when treating the SFA and popliteal artery. The Bard 5F ProSeries™ also includes:
- Crosser™ CTO Recanalization Catheter
- UltraVerse™ 035 PTA
- Ultrascore™ Focused Force PTA
- Lutonix™ 035 DCB
To learn more about the Bard 5F ProSeries™, please visit BardProSeries.com
The LifeStent™5F Vascular Stent System is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the native superficial femoral artery (SFA) and popliteal artery. The LifeStent™ 5F Vascular Stent System is available in 5 mm, 6 mm, and 7 mm diameters; and 20 mm to 170 mm in length.
Increase Procedure Efficiency with GeoAlign™
The LifeStent™ 5F Vascular Stent System features the GeoAlign™ Marking System, which is a simple-to-use, non-radiopaque ruler on the catheter shaft. The GeoAlign™ Marking System is featured on all Bard 5F ProSeries™ products. The GeoAlign™ Marking System is designed to facilitate repeatable catheter alignment at the lesion and to increase procedure efficiency by minimising fluoroscopy exposure.3
true
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
true
1 Commercially available as of December 2023
2 Based on physician ratings during animal testing. May not be indicative of clinical performance. Data on file at Bard Peripheral Vascular, Inc., Tempe, AZ.
3 The GeoAlign™ Marking System provides an approximation that may not be an exact representation of the distance traveled intravascularly and should be confirmed under fluoroscopy.
4 Freedom from TLR at 3 years: 75.5% LifeStent™ Vascular Stent arm (n=134), 41.8% PTA arm (n=72), p LifeStent™ Vascular Stent in 6 mm and 7 mm diameters and lengths of 40-80 mm. The LifeStent™ 5 mm stent diameter and LifeStent™ 5F delivery system were not included in these clinical studies.
5 Primary Patency at 2 years: 64.2% LifeStent™ Vascular Stent arm (n=89), 31.3% PTA arm (n=94), p=0.0001. Patency rates calculated when provisional stenting is considered TLR. Kaplan-Meier analysis with Mantel-Cox log-rank test. The study included LifeStent™ Vascular Stent in 6 mm, 7 mm and 8 mm diameters and lengths of 20-170 mm. The LifeStent™ 5 mm stent diameter and LifeStent™ 5F delivery system were not included in these clinical studies.
6 Primary Patency at 12 months: 81.5% all lesion lengths (n=53). This study included LifeStent™ Vascular Stent in 6 mm and 7 mm diameters and lengths of 20-200 mm. The LifeStent™ 5 mm stent diameter and LifeStent™ 5F delivery system were not included in these clinical studies.
Please consult Instructions for Use under Resources for product indications for use, contraindications, warnings, precautions, complications, adverse events and detailed safety information.
BD-117070
true